Cross Country Healthcare, Inc. (FRA:XXY)
Germany flag Germany · Delayed Price · Currency is EUR
9.05
-0.15 (-1.63%)
At close: Nov 26, 2025

Cross Country Healthcare Statistics

Total Valuation

FRA:XXY has a market cap or net worth of EUR 288.28 million. The enterprise value is 204.91 million.

Market Cap288.28M
Enterprise Value 204.91M

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date Feb 18, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 32.76M
Shares Outstanding n/a
Shares Change (YoY) -4.44%
Shares Change (QoQ) +0.10%
Owned by Insiders (%) 5.44%
Owned by Institutions (%) 92.65%
Float 28.50M

Valuation Ratios

PE Ratio n/a
Forward PE 99.01
PS Ratio 0.30
PB Ratio 0.83
P/TBV Ratio 1.51
P/FCF Ratio 7.41
P/OCF Ratio 6.24
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.05, with an EV/FCF ratio of 5.26.

EV / Earnings -15.34
EV / Sales 0.21
EV / EBITDA 10.05
EV / EBIT 55.05
EV / FCF 5.26

Financial Position

The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.01.

Current Ratio 3.45
Quick Ratio 3.38
Debt / Equity 0.01
Debt / EBITDA 0.09
Debt / FCF 0.05
Interest Coverage 1.92

Financial Efficiency

Return on equity (ROE) is -3.76% and return on invested capital (ROIC) is 0.64%.

Return on Equity (ROE) -3.76%
Return on Assets (ROA) 0.48%
Return on Invested Capital (ROIC) 0.64%
Return on Capital Employed (ROCE) 0.96%
Revenue Per Employee 100,046
Profits Per Employee -1,391
Employee Count9,605
Asset Turnover 1.99
Inventory Turnover n/a

Taxes

Income Tax -428,707
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -10.40% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -10.40%
50-Day Moving Average 10.51
200-Day Moving Average 11.83
Relative Strength Index (RSI) 33.15
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 8.77

Income Statement

In the last 12 months, FRA:XXY had revenue of EUR 960.94 million and -13.36 million in losses. Loss per share was -0.42.

Revenue960.94M
Gross Profit 193.97M
Operating Income 3.69M
Pretax Income -13.79M
Net Income -13.36M
EBITDA 17.84M
EBIT 3.69M
Loss Per Share -0.42
Full Income Statement

Balance Sheet

The company has 84.49 million in cash and 1.88 million in debt, giving a net cash position of 82.61 million.

Cash & Cash Equivalents 84.49M
Total Debt 1.88M
Net Cash 82.61M
Net Cash Per Share n/a
Equity (Book Value) 347.86M
Book Value Per Share 10.70
Working Capital 178.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 46.23 million and capital expenditures -7.31 million, giving a free cash flow of 38.93 million.

Operating Cash Flow 46.23M
Capital Expenditures -7.31M
Free Cash Flow 38.93M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 20.19%, with operating and profit margins of 0.38% and -1.39%.

Gross Margin 20.19%
Operating Margin 0.38%
Pretax Margin -1.43%
Profit Margin -1.39%
EBITDA Margin 1.86%
EBIT Margin 0.38%
FCF Margin 4.05%

Dividends & Yields

FRA:XXY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 4.44%
Shareholder Yield 4.44%
Earnings Yield -4.63%
FCF Yield 13.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:XXY has an Altman Z-Score of 5.3 and a Piotroski F-Score of 4.

Altman Z-Score 5.3
Piotroski F-Score 4